Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +1.54% | +2.59% | +7.03% |
Business Summary
Number of employees: 27
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
John Doyle
DFI | Director of Finance/CFO | 46 | 23-04-30 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-10 |
Mary Hamby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anthony Caggiano
CTO | Chief Tech/Sci/R&D Officer | 54 | 19-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
Brett Monia
BRD | Director/Board Member | 62 | 20-09-30 |
Ellen Richstone
BRD | Director/Board Member | 72 | 21-10-31 |
Jack Khattar
CHM | Chairman | 62 | 19-12-31 |
Peggy Wallace
BRD | Director/Board Member | 67 | 16-08-31 |
Aaron Fletcher
BRD | Director/Board Member | 44 | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,039,220 | 36,054,193 ( 90.05 %) | 0 | 90.05 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.03% | 79.28M | |
-1.65% | 103B | |
+6.75% | 101B | |
+7.07% | 23.07B | |
-12.60% | 22.23B | |
-5.29% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- CGTX Stock
- Company Cognition Therapeutics, Inc.